4Bernus A, Wagner BD, Accurso F, et al.Brain natriuretic peptide levels in managing pediatric patients with pulmonary arterial hypertension[J].Chest, 2009,135 (3) :745-751.
5Reynolds EW, Ellington JG, Vranicar M, et al.Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn[J].Pediatrics, 2004,114(5) :1297-1304.
6Currie PJ, Seward JB, Chan KL, et al.Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients[J].J Am Coll Cardiol, 1985,6(4) :750-756.
7Galiè N, Hoeper MM, Humbert M, et al.Guidelines for the diagnosis and treatment of pulmonary hypertension : the Task Force for the Diagnosis andTreatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the EuropeanRespiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)[J].Eur Heart J, 2009,30 (20) :2493-2537.
8Cantinotti M, Vittorini S, Storti S, et al.Diagnostic accuracy and clinical relevance of brain natriuretic peptide assay in pediatric patients with congenital heart diseases[J].J Cardiovasc Med (Hagerstown) , 2009,10 (9) :706-713.
9Nagaya N, Nishikimi T, Okano Y, et al.Plasma brain natriuretic peptide levels increase in proportion to the extend of fight ventricular dysfunction in pulmonary hypertension[J].J Am Coll Cardiol, 1998,31 (1) :202-208.
10Niizck T, Takeishi Y, Arimoto T, et al.Combination of heart-type facty acid bindy protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure[J].Circ J, 2005,69(8) :922-927.
